Literature DB >> 16597909

Use of galactomannan enzyme immunoassay for diagnosis of invasive aspergillosis in a tertiary-care center over a 12-month period.

Daniel C Zedek, Melissa B Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16597909      PMCID： PMC1448670          DOI： 10.1128/JCM.44.4.1601.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  9 in total

1.  Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

Authors:  J Maertens; J Verhaegen; K Lagrou; J Van Eldere; M Boogaerts
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

2.  Aspergillus antigen testing in bone marrow transplant recipients.

Authors:  E C Williamson; D A Oliver; E M Johnson; A B Foot; D I Marks; D W Warnock
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

3.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

Authors:  Kieren A Marr; Rachel A Carter; Fulvio Crippa; Anna Wald; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2002-02-26       Impact factor: 9.079

4.  Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients.

Authors:  Johan Maertens; Johan Van Eldere; Jan Verhaegen; Erik Verbeken; Johny Verschakelen; Marc Boogaerts
Journal:  J Infect Dis       Date:  2002-10-08       Impact factor: 5.226

5.  Detection of circulating Aspergillus fumigatus galactomannan: value and limits of the Platelia test for diagnosing invasive aspergillosis.

Authors:  Claudine Pinel; Hélène Fricker-Hidalgo; Bernadette Lebeau; Frédéric Garban; Rébecca Hamidfar; Pierre Ambroise-Thomas; Renée Grillot
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

6.  Comparison of an enzyme immunoassay and a latex agglutination system for the diagnosis of invasive aspergillosis in bone marrow transplant recipients.

Authors:  M Machetti; M Feasi; N Mordini; M T Van Lint; A Bacigalupo; J P Latgé; J Sarfati; C Viscoli
Journal:  Bone Marrow Transplant       Date:  1998-05       Impact factor: 5.483

7.  Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.

Authors:  Raoul Herbrecht; Valérie Letscher-Bru; Corina Oprea; Bruno Lioure; Jocelyn Waller; France Campos; Odile Villard; Kun-Lun Liu; Shanti Natarajan-Amé; Patrick Lutz; Patrick Dufour; Jean-Pierre Bergerat; Ermanno Candolfi
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

8.  Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis.

Authors:  J Maertens; J Verhaegen; H Demuynck; P Brock; G Verhoef; P Vandenberghe; J Van Eldere; L Verbist; M Boogaerts
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

9.  False-positive results in premature infants with the Platelia Aspergillus sandwich enzyme-linked immunosorbent assay.

Authors:  M Siemann; M Koch-Dörfler; M Gaude
Journal:  Mycoses       Date:  1998-11       Impact factor: 4.377
  9 in total
  5 in total

Review 1.  Pneumonia in the neutropenic cancer patient.

Authors:  Scott E Evans; David E Ost
Journal:  Curr Opin Pulm Med       Date:  2015-05       Impact factor: 3.155

Review 2.  Galactomannan detection for invasive aspergillosis in immunocompromised patients.

Authors:  Mariska M G Leeflang; Yvette J Debets-Ossenkopp; Junfeng Wang; Caroline E Visser; Rob J P M Scholten; Lotty Hooft; Henk A Bijlmer; Johannes B Reitsma; Mingming Zhang; Patrick M M Bossuyt; Christina M Vandenbroucke-Grauls
Journal:  Cochrane Database Syst Rev       Date:  2015-12-30

3.  Immune-Response Patterns and Next Generation Sequencing Diagnostics for the Detection of Mycoses in Patients with Septic Shock-Results of a Combined Clinical and Experimental Investigation.

Authors:  Sebastian O Decker; Annette Sigl; Christian Grumaz; Philip Stevens; Yevhen Vainshtein; Stefan Zimmermann; Markus A Weigand; Stefan Hofer; Kai Sohn; Thorsten Brenner
Journal:  Int J Mol Sci       Date:  2017-08-18       Impact factor: 5.923

Review 4.  Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis.

Authors:  Mingxiang Zou; Lanhua Tang; Shushan Zhao; Zijin Zhao; Luyao Chen; Peng Chen; Zebing Huang; Jun Li; Lizhang Chen; Xuegong Fan
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

Review 5.  Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.

Authors:  Georg Maschmeyer; Antje Haas; Oliver A Cornely
Journal:  Drugs       Date:  2007       Impact factor: 11.431
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.